Company:  OPGEN INC (OPGN)
Form Type:  DEF 14A
Filing Date:  4/25/2022 
CIK:  0001293818 
Address:  9717 KEY WEST AVENUE
SUITE 100
 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  301-869-9683 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.28  
Change: 
-0.0257 (-8.40%)  
Trade Time: 
Oct 05  
Market Cap: 
$13.53M
Trade OPGN now with

© 2022  
Description of Business
Please refer to the Glossary at the end of this Business section for definitions or descriptions of scientific, diagnostic, healthcare, regulatory, and OpGen-specific terms used in this Annual Report. Overview OpGen, Inc. (the "Company") is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. Along with our subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.
Register and access this filing in:     
  FORM DEF 14A
    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
    PROXY STATEMENT
      COMPENSATION TABLE
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      BENEFICIAL OWNERS
      NAME AND TITLE
    Report of the Audit Committee
    Certain Relationships and Related Person Transactions
    EXECUTIVE COMPENSATION
    Director Compensation
    PROPOSAL NO. ONE - ELECTION OF DIRECTORS
    PROPOSAL NO. TWO - AMENDMENT TO THE AMENDED AND RESTATED ...
    PROPOSAL NO. THREE - RATIFICATION OF INDEPENDENT ACCOUNTING FIRM
    PROPOSAL NO. FOUR- TO APPROVE THE ADJOURNMENT OF THE ANNUAL ...
    ANNUAL REPORT TO STOCKHOLDERS
    OTHER MATTERS
    STOCKHOLDER PROPOSALS
    PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS